InsiderTrades.com logo

NBSE Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 7.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

NeuBase Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at NeuBase Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NeuBase Therapeutics Share Price & Price History

Current Price: $0.38
Price Change: +0.30 (1.20%)
As of 09/20/2024 01:00 AM ET

This chart shows the closing price history over time for NBSE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

NeuBase Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2023Corp SymetryxMajor ShareholderSell129,108$1.44$185,915.52153,337View SEC Filing Icon  
9/11/2023Corp SymetryxMajor ShareholderSell3,376$1.44$4,861.44472,926View SEC Filing Icon  
9/7/2023Corp SymetryxMajor ShareholderSell74,852$1.80$134,733.60605,149View SEC Filing Icon  
9/1/2023Corp SymetryxMajor ShareholderBuy61,076$0.98$59,854.48680,081View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NeuBase Therapeutics (NASDAQ:NBSE)

12.37% of NeuBase Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NBSE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NeuBase Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2023Prelude Capital Management LLC15,550$29K0.0%-95.0%0.920%Search for SEC Filing on Google Icon
8/10/2023Jacob Asset Management of New York LLC15,655$29K0.0%-95.0%0.926%Search for SEC Filing on Google Icon
8/1/2023Carnegie Mellon University46,970$88K0.1%-95.0%2.779%Search for SEC Filing on Google Icon
7/28/2023Decheng Capital Management III Cayman LLC50,000$92K0.0%-95.0%2.959%Search for SEC Filing on Google Icon
2/9/2023CM Management LLC350,000$67K0.1%-22.2%1.060%Search for SEC Filing on Google Icon
11/14/2022Worth Venture Partners LLC212,035$84K0.1%-17.4%0.657%Search for SEC Filing on Google Icon
11/4/2022CM Management LLC450,000$0.18M0.2%+21.6%1.395%Search for SEC Filing on Google Icon
8/8/2022CM Management LLC370,000$0.39M0.4%+13.8%1.147%Search for SEC Filing on Google Icon
7/29/2022Perkins Capital Management Inc.81,500$86K0.1%+22.6%0.253%Search for SEC Filing on Google Icon
5/12/2022AIGH Capital Management LLC1,027,585$1.93M0.5%+2.7%3.136%Search for SEC Filing on Google Icon
5/10/2022Decheng Capital Management III Cayman LLC1,000,000$1.88M0.6%N/A3.052%Search for SEC Filing on Google Icon
5/9/2022CM Management LLC325,000$0.61M0.5%+116.7%0.992%Search for SEC Filing on Google Icon
5/9/2022Wealthsource Partners LLC23,850$45K0.0%N/A0.073%Search for SEC Filing on Google Icon
5/4/2022Waldron Private Wealth LLC79,620$0.15M0.0%+296.4%0.243%Search for SEC Filing on Google Icon
4/20/2022Perkins Capital Management Inc.66,500$0.13M0.1%+121.7%0.203%Search for SEC Filing on Google Icon
2/14/2022Fifth Lane Capital LP20,000$56K0.0%N/A0.061%Search for SEC Filing on Google Icon
2/10/2022Perkins Capital Management Inc.30,000$84K0.1%+42.9%0.092%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC1,000,285$2.81M0.9%N/A3.057%Search for SEC Filing on Google Icon
2/9/2022Jacob Asset Management of New York LLC426,424$1.20M0.5%+4.6%1.303%Search for SEC Filing on Google Icon
2/2/2022CM Management LLC150,000$0.42M0.3%+100.0%0.458%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP178,821$0.65M0.0%-12.4%0.547%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP50,310$0.18M0.0%-63.1%0.154%Search for SEC Filing on Google Icon
11/15/2021Tocqueville Asset Management L.P.74,000$0.27M0.0%+156.9%0.226%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP351,178$1.27M0.1%+1.5%1.073%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC391,193$1.41M0.0%-7.9%1.196%Search for SEC Filing on Google Icon
11/12/2021Stonepine Capital Management LLC109,742$0.40M0.2%+253.2%0.335%Search for SEC Filing on Google Icon
11/12/2021Jacob Asset Management of New York LLC407,500$1.47M0.5%+17.9%1.246%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.104,796$0.38M0.0%-4.5%0.320%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.81,716$0.30M0.0%-6.0%0.250%Search for SEC Filing on Google Icon
11/8/2021CM Management LLC75,000$0.27M0.2%N/A0.229%Search for SEC Filing on Google Icon
10/25/2021Perkins Capital Management Inc.21,000$76K0.0%+41.9%0.064%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC174,020$0.83M0.0%+276.2%0.532%Search for SEC Filing on Google Icon
8/16/2021Royal Bank of Canada85,955$0.41M0.0%+664.5%0.263%Search for SEC Filing on Google Icon
8/16/2021State Street Corp23,813$0.11M0.0%-90.8%0.073%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.109,685$0.53M0.0%+5.2%0.335%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NeuBase Therapeutics logo
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
Read More on NeuBase Therapeutics

Today's Range

Now: $0.38
Low: $0.38
High: $0.38

50 Day Range

MA: $0.38
Low: $0.38
High: $0.38

52 Week Range

Now: $0.38
Low: $0.36
High: $4.80

Volume

N/A

Average Volume

N/A

Market Capitalization

$1.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A